Same Indication

Nivolumab vs Norfloxacin

Nivolumab vs Norfloxacin: Overview

This comparison examines the pharmacological differences between Nivolumab and Norfloxacin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Norfloxacin: Second-generation fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Norfloxacin — 3-4 hours.

Chemical Properties

Molecular Formula: Norfloxacin — C16H18FN3O3.

Molecular Weight: Norfloxacin — 319.3310 g/mol.

Type: Nivolumab — Antibody; Norfloxacin — Small molecule.